Mobile

A multi-centre, randomized, double-blind, active control, parallel-group, 2-arm study to investigate the effect of ethinylestradiol / drospirenone / (0.02 mg/3 mg) oral contraception in a 24/4 regimen...

Mise à jour : Il y a 4 ans
Référence : EUCTR2009-014911-11

A multi-centre, randomized, double-blind, active control, parallel-group, 2-arm study to investigate the effect of ethinylestradiol / drospirenone / (0.02 mg/3 mg) oral contraception in a 24/4 regimen compared to ethinylestradiol / desogestrel (0.02 mg/0.15 mg) oral contraception in a 21/7 regimen on hormone withdrawal associated symptoms in otherwise healthy women after 4 cycles of treatment

Femme Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To show superiority of 24/4 OC to 21/7 OC with regard to changes in frequency and intensity of hormone withdrawal associated symptoms on cycle days 22 – 28 from baseline to cycle 4 in approximately 550 women.

Critère d'inclusion

  • Oral Contraception

Liens